top of page

Centrophenoxine

Life extension.

 

Aging of cell membranes: facts and theories.

 

On the role of intracellular physicochemistry in quantitative gene expression during aging and the effect of centrophenoxine. A review.

 

Gerontopsychological studies using NAI ('Nurnberger Alters-Inventar') on patients with organic psychosyndrome (DSM III, Category 1) treated with centrophenoxine in a double blind, comparative, randomized clinical trial.

 

The effect of centrophenoxine on regional cerebral blood flow in man (author's transl).

 

Critical review of clinical trials in senile dementia--I.

 

A survey of the available data on a new nootropic drug, BCE-001.

 

Current topics in tardive dyskinesia in Japan.

 

Pharmacological interventions against aging through the cell plasma membrane: a review of the experimental results obtained in animals and humans.

 

Some pharmacological effects of centrophenoxine and its components in mice.

 

Paradoxical effects of phenothiazines.

 

Electron spin resonance spectroscopic demonstration of the hydroxyl free radical scavenger properties of dimethylaminoethanol in spin trapping experiments confirming the molecular basis for the biological effects of centrophenoxine.

 

Correction by centrophenoxine of abnormal catecholamine response to postural stimulus in patients with orthostatic hypotension due to brainstem ischemia.

 

Effects of pyrithioxine, centrophenoxine, and piracetam on verbal learning.

 

The influence of centrophenoxine (Lucidril) on the course of sleep deprivtion in alcoholics.

 

The effect of centrophenoxine on EEG vigilance in the course of sleep deprivation and on the EEG pattern of all-night sleep.

 

Construction and performance characteristics of new ion selective electrodes based on carbon nanotubes for determination of meclofenoxate hydrochloride.

 

The efficacy of the cerebral metabolic enhancers in the treatment of senile dementia.

 

Solving the riddle of lipofuscin's origin may uncover clues to the aging process.

 

Inability to deactivate the sympathetic nervous system in patients with brainstem infarction; correction of the disorder by centrophenoxine administration.

 

Lucidril for autism.

 

Kinetics of hydrolysis of meclofenoxate hydrochloride in human plasma.

 

The differential effects of meclofenoxate on memory loss in the elderly.

 

Effect of centrophenoxine and BCE-001 treatment on lateral diffusion of proteins in the hepatocyte plasma membrane as revealed by fluorescence recovery after photobleaching in rat liver smears.

 

A method for measuring mental performance in the elderly and its use in a pilot clinical trial of meclofenoxate in organic dementia (preliminary communication).

 

Serial testing in assessing the effect of meclofenoxate on patients with memory defects.

 

Superiority of antagonic-stress composition versus nicergoline in gerontopsychiatry.

 

Brain cholinesterases: III. Future perspectives of AD research and clinical practice.

 

A simple and sensitive HPLC method for quantification of the metabolin of meclofenoxate in human plasma.

 

Bioequivalence and pharmacokinetic comparison of a single 200-mg dose of meclofenoxate hydrochloride capsule and tablet formulations in healthy Chinese adult male volunteers: a randomized sequence, open-label, two-period crossover study.

 

Pharmacotherapy for age-related behavioral deficiencies.

 

Double-blind controlled trial of lucidril (meclofenoxate) in the post-traumatic syndrome, especially dizziness.

 

Antagonic-stress. A new treatment in gerontopsychiatry and for a healthy productive life.

Effects of bonellin on lipids.

 

The influence of centrophenoxine and ephedrine on the hyporeactivity of the autonomic centres in patients with cerebral infarction.

 

Acute effects of ethanol (0.5 mg/kg) and its interaction with diazepam (5 mg) and meclophenoxate (100 mg) on the blood pressure, the body temperature and the heart rate in man.

 

Centrophenoxine and chlormethiazol in the treatment of delirium tremens.

 

Viral hepatitis with intracytoplasmic cholestasis and cholesterol crystals in a drug addict.

 

Effectivity of Cavinton and Lucidril in the treatment of hearing defects of different origin.

 

Hypoxia and some therapeutic problems in gerontopsychiatry.

 

The quantitative assessment of lipofuscin pigment, cytoplasmic RNA and nucleolar volume in senile dementia.

 

Meclofenoxate therapy in tardive dyskinesia: a preliminary report.

 

Immediate effects of neurodynamic substances on verbal performance in the treatment of aphasia.

 

On acute effects of some drugs on the higher nervous activity in man. Ethanol (0.5 g/kg) and its interaction with diazepam (5 mg) and meclophenoxate (100 mg). Part LVIII.

 

Drugs for dementia.

 

New psychoactive drugs in psychogeriatrics.

 

Effect of centrophenoxine on human embryonic lung cells in culture [proceedings].

 

Further study on pharmacology of meclophenoxate and it components in mice.

 

Treatment of encephalitis in children with centrophenoxin as a supplementary drug.

 

The psychological aspect of gynaecology. The mechanism of neurosis and lucidril therapy.

 

Effect of meclophenoxate (Cetrexin, Spofa) on the establishment of verbal associations [proceedings].

 

pH-dependent degradation and stabilization of meclofenoxate hydrochloride by human serum albumin.

 

Assessment of various psychopharmacological combinations in the treatment of presenile and senile primary degenerative dementia.

 

Effects of different drugs on the higher nervous activity in man. Meclophenoxate.

 

Effects of nootropic drugs on dopaminergic systems in the CNS.

 

The effect of meclofenamic acid on plasma uric acid levels.

 

On a successfully treated acute oral paraoxone (E 600) poisoning.

 

Effects of various additives on in vitro survival time of human fibroblasts.

 

Clofibrate and a related compound suppress TSH secretion in primary hypothyroidism.

bottom of page